↓ Skip to main content

Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA

Overview of attention for article published in Digestive Diseases and Sciences, February 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
2 news outlets
twitter
1 X user

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
55 Mendeley
Title
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA
Published in
Digestive Diseases and Sciences, February 2016
DOI 10.1007/s10620-016-4091-8
Pubmed ID
Authors

Jason Y. Park, Kerry B. Dunbar, Midori Mitui, Christina A. Arnold, Dora M. Lam-Himlin, Mark A. Valasek, Irene Thung, Chinemerem Okwara, Elizabeth Coss, Byron Cryer, Christopher D. Doern

Abstract

Helicobacter pylori antibiotic resistance leads to frequent treatment failure. However, the current US prevalence of H. pylori clarithromycin resistance and treatment failure is unknown. To determine the prevalence of clarithromycin-resistant H. pylori and its impact on treatment failure in the USA. A multicenter, retrospective, cohort study for clarithromycin-resistant H. pylori was conducted over four academic medical centers in different geographic regions of the USA. Gastric biopsy material, residual from standard clinical pathologic examination, was examined for clarithromycin resistance by DNA sequencing of H. pylori 23S rRNA. One hundred and twenty-four cases of H. pylori gastritis were examined from medical centers in four different geographic regions of the USA. The overall prevalence of clarithromycin resistance was 32.3 % (range 23.1-45.8 %). There was no significant difference in the prevalence of clarithromycin resistance by study site, gender, age, or race/ethnicity. In a subset of 67 patients that had clinical follow-up data, the overall prevalence of clarithromycin resistance was 31.3 %. There was a 2.9-fold increase (p = 0.002) in treatment failure for cases with clarithromycin resistance (57.1 %) compared to wildtype H. pylori (19.6 %). H. pylori clarithromycin resistance in the USA exceeds the estimated 20 % prevalence compatible with successful empiric antibiotic therapy. This resistance resulted in a significant rate of treatment failure in all sites surveyed. Empiric therapy in the USA should be used with caution until there is better regional or local determination of H. pylori antibiotic resistance.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 20%
Student > Ph. D. Student 7 13%
Researcher 6 11%
Other 5 9%
Student > Doctoral Student 3 5%
Other 7 13%
Unknown 16 29%
Readers by discipline Count As %
Medicine and Dentistry 12 22%
Biochemistry, Genetics and Molecular Biology 7 13%
Agricultural and Biological Sciences 5 9%
Immunology and Microbiology 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 4 7%
Unknown 21 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2024.
All research outputs
#2,600,255
of 25,354,251 outputs
Outputs from Digestive Diseases and Sciences
#285
of 4,624 outputs
Outputs of similar age
#39,445
of 304,487 outputs
Outputs of similar age from Digestive Diseases and Sciences
#7
of 63 outputs
Altmetric has tracked 25,354,251 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,624 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 304,487 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.